CD4 and graft versus host disease: Compared with recipients of BM+CD4+, recipients of BM+CD4++DN had elevated serum IFNγ (Fig. 3A, p = 0.047), suggesting that IFNγ might contribute to B6.lpr DN T cell-mediated suppression of GVHD.